Atlassian Corporation PLC (NASDAQ:TEAM – Get Free Report) CEO Michael Cannon-Brookes sold 7,665 shares of Atlassian stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $126.11, for a total value of $966,633.15. Following the sale, the chief executive officer directly owned 360,255 shares of the company’s stock, valued at $45,431,758.05. This trade represents a 2.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Michael Cannon-Brookes also recently made the following trade(s):
- On Tuesday, January 20th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $118.19, for a total transaction of $905,926.35.
- On Friday, January 16th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $120.82, for a total transaction of $926,085.30.
- On Wednesday, January 14th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $133.66, for a total value of $1,024,503.90.
- On Monday, January 12th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.15, for a total value of $1,127,904.75.
- On Friday, January 9th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $145.91, for a total value of $1,118,400.15.
- On Wednesday, January 7th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $161.11, for a total transaction of $1,234,908.15.
- On Monday, January 5th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $154.20, for a total transaction of $1,181,943.00.
- On Friday, January 2nd, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $156.15, for a total transaction of $1,196,889.75.
- On Wednesday, December 31st, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $162.68, for a total transaction of $1,246,942.20.
- On Monday, December 29th, Michael Cannon-Brookes sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $163.66, for a total value of $1,254,453.90.
Atlassian Price Performance
NASDAQ TEAM traded up $3.31 during trading hours on Friday, reaching $131.75. The company’s stock had a trading volume of 5,861,070 shares, compared to its average volume of 4,577,891. The firm has a market capitalization of $34.66 billion, a price-to-earnings ratio of -185.56, a P/E/G ratio of 18.96 and a beta of 0.88. The company’s 50-day moving average is $151.11 and its two-hundred day moving average is $164.70. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.26 and a quick ratio of 1.26. Atlassian Corporation PLC has a 1-year low of $115.53 and a 1-year high of $326.00.
Key Stories Impacting Atlassian
Here are the key news stories impacting Atlassian this week:
- Positive Sentiment: Atlassian exec Shamik Sharma outlines an AI “ticketless” vision that could streamline service workflows and help drive product differentiation and enterprise adoption. Ticketless Future with AI
- Positive Sentiment: Event coverage from Atlassian’s Team on Tour (Bengaluru) highlights AI features positioning the product as a teammate for users — a narrative that supports upside if adoption accelerates. When AI becomes a teammate
- Positive Sentiment: MarketBeat argues TEAM is deeply oversold ahead of earnings, notes several buy/Outperform reiterations (Mizuho, Citi, Piper Sandler, BTIG) and says fundamentals/revenue trends still look solid — a potential catalyst if Atlassian again beats estimates. Atlassian Has Been Crushed—But the Setup Into Earnings Is Shifting
- Neutral Sentiment: Brokerage consensus remains “Moderate Buy” by count, reflecting mixed analyst views even as some firms lower targets but keep positive ratings. This keeps the stock tethered to next earnings and guidance. Consensus Recommendation: Moderate Buy
- Neutral Sentiment: Valuation pieces note short‑term pain from AI concern noise and Data Center/cloud pricing changes; these analyses assess whether the sell‑off already prices in slower growth or overstates disruption risk. Assessing Atlassian Valuation
- Negative Sentiment: Mizuho and TD Cowen have signaled more cautious views recently — Mizuho (per some reports) trimmed forecasts/targets and TD Cowen cut its target and moved to Hold — reducing near‑term upside expectations. Mizuho Issues Pessimistic Forecast
- Negative Sentiment: Analyst downgrades and note-driven skepticism have pushed TEAM to new multi‑year/52‑week lows in recent sessions, which can trigger additional selling and margin pressure ahead of a definitive rebound. Hits New 52-Week Low After Analyst Downgrade
- Negative Sentiment: Founder/director insider sales (Scott Farquhar and others) — repeated small sells in January — have been disclosed and some investors view these as a negative signal even though founders retain large stakes. Scott Farquhar Sells Shares
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Capco Asset Management LLC purchased a new position in Atlassian during the second quarter worth approximately $25,000. Physician Wealth Advisors Inc. increased its stake in shares of Atlassian by 60.4% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock worth $26,000 after acquiring an additional 61 shares during the last quarter. Atlantic Union Bankshares Corp raised its holdings in shares of Atlassian by 19,900.0% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock worth $32,000 after acquiring an additional 199 shares during the period. Board of the Pension Protection Fund acquired a new position in shares of Atlassian during the 4th quarter valued at about $32,000. Finally, Geneos Wealth Management Inc. grew its holdings in shares of Atlassian by 447.2% in the first quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock valued at $42,000 after purchasing an additional 161 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
TEAM has been the topic of several research analyst reports. Sanford C. Bernstein lifted their target price on shares of Atlassian from $290.00 to $304.00 and gave the company an “outperform” rating in a research report on Tuesday, November 18th. BMO Capital Markets raised their price target on shares of Atlassian from $190.00 to $195.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. TD Cowen lowered their price objective on Atlassian from $205.00 to $175.00 and set a “hold” rating on the stock in a report on Tuesday. Weiss Ratings reissued a “sell (e+)” rating on shares of Atlassian in a report on Wednesday. Finally, BTIG Research restated a “buy” rating and issued a $220.00 target price on shares of Atlassian in a research report on Tuesday, January 13th. Twenty-one equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $235.38.
Atlassian Company Profile
Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.
Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.
Recommended Stories
- Five stocks we like better than Atlassian
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.
